Delivery Order SPE2DR25D9133-SPE2DR26FCFN7
- Not listed
- The Defense Logistics Agency awarded a $24,937.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra 30 mg/mL syringes. The delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under...
- The Defense Logistics Agency awarded a $9,975 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The order, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will occur at the contractor's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,435 to DMS Pharmaceutical Group Inc. for Fasenra 30 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by November 3, 2025, and represents one of numerous...
- The Defense Logistics Agency (DLA) awarded a $14,962.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The award, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and was issued without a set-aside designation. DMS Pharmaceutical Group is performing work at its headquarters location in Park Ridge, Illinois. This...
- The Defense Logistics Agency (DLA) awarded a $39,900 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/mL syringes. The award, issued on December 17, 2025, with a completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract leverages DMS Pharmaceutical Group's position as a regional prime vendor under the DLA's Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a $9,975 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Fasenra Pen 30 mg/ml on January 7, 2026. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G...
- The Defense Logistics Agency has awarded a delivery order valued at $9,774.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA 30 mg/ml syringes. DMS Pharmaceutical Group Inc. is a critical supplier within the federal pharmaceutical supply chain and has been registered in the System for Award Management since 2001. This delivery order was issued without a set-aside designation, reflecting the...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $4,987.52 to DMS Pharmaceutical Group Inc. for Fasenra Pen 30mg/ml, an injectable pharmaceutical product used in respiratory and immunological treatments. This delivery order, awarded on December 2, 2025, with an ultimate completion date of the same day, carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFN7Delivery Order
The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support, including branded and generic prescription drugs, biologics, and medical consumables, to Department of Defense healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group serves as a critical supplier for military medical operations globally, with this delivery order exemplifying the recurring pharmaceutical needs fulfilled through the contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 1/5/26 |